HUNDREDS of Australian
pharmaceutical jobs are set to be
created by CSL Limited, with a new
Privigen manufacturing facility to
be built at its Broadmeadows site in
Victoria as part of a $250 million
capital expenditure program.
Privigen is CSL’s proprietary liquid
intravenous immunoglobulin (IVIg)
therapy which is stabilised using
the amino acid Proline.The above article was sent to subscribers in Pharmacy Daily's issue from 17 Aug 11 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 Aug 11
MAYNE Pharma Group Limited has filed a patent infringement suit against Sun Pharmaceutical Industries Ltd and Inc., in the United States District Court, according to yesterday’s ASX announcement.
PHARMACY Connect 2024 conference will feature a provocative ‘Great Debate’ during the Harm Minimisation Workshop on Thu 05 Sep at the Hyatt Regency in Sydney.
LTR Pharma Limited has successfully raised $10.5 million through a share placement to sophisticated and new institutional investors, significantly surpassing initial demand.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.